RESPONSE TO INTRAVITREAL AFLIBERCEPT IN A PATIENT WITH PERIPHERAL EXUDATIVE HEMORRHAGIC CHORIORETINOPATHY

    loading  Checking for direct PDF access through Ovid

Abstract

Purpose:

To draw attention to a novel treatment agent for vision loss associated with peripheral exudative hemorrhagic chorioretinopathy.

Methods:

The case of an 83-year-old man suffering with loss of left visual acuity vision in the context of vitreous hemorrhage secondary to peripheral exudative hemorrhagic chorioretinopathy is described.

Results:

Resolution of vitreous hemorrhage and subretinal hemorrhage was demonstrated after treatment with aflibercept.

Conclusion:

Peripheral exudative hemorrhagic chorioretinopathy is discussed in terms of its presentation, pathophysiology, and existing treatment methodologies.

Related Topics

    loading  Loading Related Articles